Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: Where we stand and where we go

ANTONIO LOPEZ BELTRAN2026-01-292026-01-29201910.2217/fon-2019-02172-s2.0-85069520160https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/30637Cancer ResearchOncologyCancer ResearchOncologyPredictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: Where we stand and where we goreview article